Show simple item record

AuthorLang, Gabrielle E.dc.contributor.author
AuthorBerta, Andrasdc.contributor.author
AuthorEldem, Bora M.dc.contributor.author
AuthorSimader, Christiandc.contributor.author
AuthorSharp, Diannedc.contributor.author
AuthorHolz, Frank G.dc.contributor.author
AuthorSutter, Floriandc.contributor.author
AuthorGerstner, Ortruddc.contributor.author
AuthorMitchell, Pauldc.contributor.author
AuthorRESTORE Extension Study Grpdc.contributor.author
Date of accession2018-08-28T07:10:49Zdc.date.accessioned
Available in OPARU since2018-08-28T07:10:49Zdc.date.available
Date of first publication2013dc.date.issued
Languageendc.language.iso
PublisherUniversität Ulmdc.publisher
Keywordplus prompt laserdc.subject
Keyworddeferred laserdc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
TitleTwo-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Studydc.title
Resource typeWissenschaftlicher Artikeldc.type
InstitutionUKU. Klinik für Augenheilkundeuulm.affiliationSpecific
DCMI TypeTextuulm.typeDCMI
CategoryPublikationsnachweiseuulm.category
DOI (external)10.1016/j.ophtha.2013.02.019dc.identifier.doiExternal
Source - Title of sourceOphthalmology: Journal of The American Academy of Ophthalmologysource.title
Source - Place of publicationElsevier Sciencesource.publisher
Source - Volume120source.volume
Source - Issue10source.issue
Source - Year2013source.year
Source - From page2004source.fromPage
Source - To page2012source.toPage
Source - ISSN0161-6420source.identifier.issn
Source - eISSN1549-4713source.identifier.eissn
FundingNovartis Pharma AG, Basel, Switzerlanduulm.funding
Open AccessNouulm.OA
Suitable communityUniversitätsklinikum Ulmuulm.community
WoS000325086400016uulm.identifier.wos
University Bibliographyjauulm.unibibliographie


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record